PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
78.41
ESG score exceeding 1.2x RVPH's 63.02. Mohnish Pabrai would examine if this ESG advantage creates sustainable competitive moats.
78.54
Environmental score 1.1-1.2x RVPH's 70.36. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
90.14
Social score exceeding 1.2x RVPH's 54.02. Mohnish Pabrai would examine if this social advantage creates sustainable talent and customer acquisition advantages.
66.56
Similar governance score to RVPH's 64.69. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.